Abstract
The Oxford Dictionary defines depression as a state of ‘low spirits or vitality’. Clearly, this state has been experienced by most people who have been subject to a major emotional crisis of disappointment at some stage during their lives. However, the psychiatrist is seldom concerned with such a mood change unless it persists for such a long time that it severely incapacitates the individual. Should the depressed mood be associated with feelings of guilt, suicidal tendencies and disturbed bodily functions (such as loss of weight, anorexia and abnormal sleep patterns) that may persist for weeks or even months and often with no obvious initiatory cause, then psychiatric assistance is usually required. It is not proposed to discuss the different types of psychiatric depression other than to emphasise that depression is frequently associated with anxiety or less frequently with mania. For these reasons, it is often desirable to select drugs which can ameliorate the additional symptoms as well as the underlying depression. A detailed account of the classification of depression and clinical aspects of this condition which are of relevance to the clinical neuropharmacologist has been given by Andreasen and Spitzer (1981).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andreasen, N. C. and Spitzer, R. L. (1981). Classification of psychiatric disorders. In Van Praag, H. M., Lader, M. A., Rafaelson, O. J. and Sachar, E. J. (Eds.), Handbook of Biological Psychiatry. Part I: Disciplines Relevant to Biological Psychiatry. Marcel Dekker, New York
Angst, J., Antenrieth, V., Brem, F., Konkkron, M., Meyer, A., Stassen, H. W. and Storck, U. (1979). Preliminary results of treatment with β-endorphin in depression. In Usdin, E., Bunney, W. E. and Kline, N. S. (Eds.), Endorphins in Mental Health Research, pp. 518–528. Macmillan, London
Asberg, M., Thoren, P., Traskman, L., Bertilsson, L. and Ruigleergern, N. (1976). Serotonin depression: a biochemical sub-group within the affective disorders. Science, N.Y., 191, 478
Ashcroft, G. W., Eccleston, D., Murray, L. G., Glen, A. J., Crawford, J. B. B., Pullow, J. A., Shields, P. J., Walter, D. S., Blackburn, D. S., Chonnechan, J. M. and Lonergan, M. (1982). Modified amine hypothesis for the aetiology of affective illness. Lancet, ii, 573
Axelrod, J. (1981). Catecholamine neurotransmitters, psychoactive drugs and biological clocks. J. Neurosurg., 55, 669
Ayd, F. J. and Blackwell, B. (Eds.) (1970). Discoveries in Biological Psychiatry. Lippincott, Philadelphia
Baldessarini, R. J. (1981), A summary of biomedical aspects of mood disorders. McLean Hosp. J., 6, 1
Ballin, J., Gottfires, C-G., Karlsson, I., Lindstedt, G., Langstrom, G. and Walinder, J. (1983). Dexamethasone suppression test and serum prolactin in dementia disorders. Br. J. Psychiat., 143, 277
Banerjee, S. P., Kung, L. S., Riggi, S. J. and Chanda, S. K. (1977). Development of β-adrenergic receptor subsensitivity by antidepressants. Nature, Lond., 268, 455
Baran, L., Maj, J., Rogoz, Z. and Skuza, G. (1979). On the antiserotonin action of trazodone. Pol J. Pharmacol., 31, 25
Beaumont, A. and Hughes, J. (1979). Biology of opioid peptides. Ann. Rev. Pharmacol., 19, 245
Beskow, R. J., Gottfires, C. G., Ross, B. E. and Winblad, B. (1976). Determination of mono-amines and monoamine metabolites in the human brain: post mortem studies in a group of suicides and in a control group. Acta Psychiat. Neurol. Scand., 53, 7
Bevan, P., Bradshaw, C. M. and Szabadi, E. (1975). Effects of iprindole on responses of single cortical and caudate neurons to monoamines and acetylcholine. Br. J. Pharmacol., 55, 17
Biegon, A. and Samuel, D. (1980). Interaction of tricyclic antidepressants with opiate receptors. Biochem. Pharmacol., 29, 460
Bielski, R. J. and Friedel, R. O. (1976). Prediction of tricyclic antidepressant response: a critical review. Arch. Gen. Psychiat., 33, 1479
Blumberg, P., Kopin, I. J., Gordon, E. K., Markey, S. P. and Ebert, M. H. (1980). Conversion of MHPG to vanillylmandelic acid: implications for the importance of urinary MHPG. Arch. Gen. Psychiat., 37, 1095
Bocknik, S. E. and Kulkarni, A. S. (1974). Effect of a decarboxylate inhibitor (Ro. 4–4602) on 5-HTP induced muricide blockade in rats. Neuropharmacology, 13, 279
Bowers, M. B. (1972). Cerebrospinal fluid 5-HIAA and HVA following probenecid in unipolar depressives treated with amitriptyline. Psychopharmacology, 23, 26
Bowlby, J. (1960). Grief and mourning in infancy and early childhood. Psychoanal Study Child., 15, 9
Brambilla, F., Smeraldi, E., Sacchetti, E., Negri, F., Cocchi, D. and Muller, E. E. (1978). Deranged anterior pituitary responsiveness to hypothalamic hormones in depressed patients. Arch. Gen. Psychiat., 35, 1231
Briley, M. and Langer, S. Z. (1981). Sodium dependency of 3H-imipramine binding in rat cerebral cortex. Europ. J. Pharmacol., 72, 377
Briley, M., Langer, S. Z., Raisman, R., Sechter, D. and Zarifian, E. (1980). 3H-imipramine binding sites are decreased in platelets of untreated depressed patients. Science, N. Y., 303, 1209
Briley, M. S., Raisman, R. and Langer, S. Z. (1979). Human platelets possess high affinity sites for 3H-imipramine. Europ. J. Pharmacol., 58, 347
Cairncross, K. D., Cox, B., Forster, C. and Wren, A. F. (1979). Olfactory projection system, drugs and behaviour: a review. Psychoneuroendocrinology, 4, 253
Carroll, B. J., Feinberg, M., Greden, J. F., Farika, J., Albala, A. A., Haskett, R. F., McI. James, N., Kron, F. Z., Lohre, N., Steiner, M., de Vignet, J. P. and Xoung, E. (1981). A specific laboratory test for the diagnosis of melancholia: standardization, validation and clinical utility. Arch. Gen. Psychiat., 38, 15
Carroll, B. J. and Mendels, J. (1976). Neuroendocrine regulation in affective disorders, In Sachar, E. J. (Ed.), Hormones, Behaviour and Psychopathology, pp. 193–224. Raven Press, New York
Chase, T. N., Gordon, E. K. and Ng, L. K. Y. (1973). Norepinephrine metabolism in the CNS of man: studies using MHPG levels in CSF. J. Neurochem., 21, 581
Chiodo, L. A. and Antelman, S. M. (1980). Tricyclic antidepressants induce sub sensitivity of pre-synaptic dopamine autoreceptors. Europ. J. Pharmacol., 64, 203
Cochran, E., Robins, E. and Grote, S. (1976). Regional serotonin level in brain: comparison of depressive suicides and alcoholic suicides with controls. Biol. Psychiat., 11, 283
Cohn, C. K., Dunner, D. L. and Axelrod, J. (1970). Reduced catechol-o-methyltransferase activity in red blood cells of women with primary affective disorder. Science, N. Y., 170, 1323
Coppen, A., Swade, C. and Woods, K. (1978). Platelet 5-hydroxytryptamine accumulation in depressive illness. Clin. Chim. Acta, 87, 165
Costain, D. W., Green, A. R. and Grahame-Smith, D. G. (1979). Enhanced 5-hydroxytryptamine mediated behavioural responses in rats following electroconvulsive shock. Psycho-pharmacology, 61, 167
Daiguji, M., Meltzer, H. Y., Tong, C., U’Prichard, D., Young, M. and Kravitz, H. (1981). α-Adrenergic receptors in platelet membranes of depressed patients: no change in number or 3H-yohimbine affinity. Life Sci., 29, 2059
De Montigny, C. and Aghajanian, G. K. (1978). Tricyclic antidepressants: long term treatment increases responsivity of rat forebrain neurons to serotonin. Science, N.Y., 202, 1303
Dunner, D. L., Levitt, M., Kumbaraci, J. and Fieve, R. R. (1977). Erythrocyte catechol-o-methyl transferase activity in primary affective disorder. Biol. Psychiat., 12, 237
Earley, B., Van Delft, A. M. L., Hasan, F. and Leonard, B. E. (1984). The effect of an ACTH 4–9 analogue (Org. 2766) on some rodent models of depression. In Burrows, G. D. (Ed.), Biological Psychiatry: Recent Studies. John Libby, London (In press)
Eisenstein, N., Iorid, L. C. and Clody, D. E. (1982). Role of serotonin in the blockade of muricidal behaviour by tricyclic antidepressants. Pharmacol. Biochem. Behav., 17, 847
Everett, G. M. and Tolman, J. E. O. (1959). Mode of action of Rauwolfia alkaloids and motor activity, In Masserman, J. (Ed.), Biological Psychiatry, pp. 75–87. Grune and Stratton, New York
Fabre, L. F. (1976). Pilot open label study with alprazolam (U-31; 889) in out patients with neurotic depression. Curr. Therap. Res., 19, 661
Fabre, L. F. and McLendon, D. M. (1980). A double-blind study comparing the efficacy and safety of alprazolam with imipramine and placebo in primary depression. Curr. Therap. Res., 27, 474
Ferris, R. M., White, H. L., Cooper, B. R., Maxwell, R. A., Tang, F. L. M., Beanan, O. J. and Russell, A. (1981). Some neurochemical properties of a new antidepressant, bupro-pion hydrochloride. Drug Develop. Res., 1, 21
Frazer, A. (1975). Adrenergic response in depression: implications for a receptor deficit. In Mendel, J. (Ed.), The Psychobiology of Depression, pp. 7–26. Spectrum, New York
Gandolfi, O., Barbaccia, M. L., Chuang, D. M. and Costa, E. (1983). Daily bupropion injections for three weeks attenuate the NE-stimulation of adenylate cyclase and the number of β-adrenergic recognition sites in rat frontal cortex. Neuropharmacology, 22, 927
Garcia-Sevilla, J. A., Zis, A. F., Zelnick, T. C. and Smith, C. B. (1981). Tricyclic antidepressant drug treatment decreases α2 -adrenoceptors in human platelet membranes. Europ. J. Pharmacol, 69, 121
Garrer, D. L., Pandey, S. N., Dekirmenjian, H. and Deleon-Jones, F. (1975). Growth hormones and catecholamines in affective disease. Am. J. Psychiat., 132, 1149
Gershon, E. S., Targum, S. D., Leckman, J. F. and Murphy, D. L. (1979). Platelet mono-amine oxidase (MAO) activity and genetic vulnerability to bipolar affective illness. Psychopharmacol. Bull., 15, 27
Gibbons, J. L. and Glusman, M. (1978). Effects of quipazine, fluoxetine and fenfluramine on muricide in rats. Fed. Proc., 39, 257
Glazer, H. I. and Weiss, J. M. (1976). Long-term interference effect. An alternative to ‘learned helplessness’. J. Exp. Psychol. Anim. Behav. Proc., 2, 202
Gold, P. W., Post, R. M., Weingartner, H. and Goodwin, F. K. (1981). Central peptide function in affective illness: arginine vasopressin as a model system. Adv. Biol. Psychiat., 7, 42
Goodwin, F. K. and Post, R. M. (1973). The use of probenecid in high doses for the estimation of central serotonin turnover in affective illness and addicts on methadone. In Barchas, J. D. and Usdin, E. (Eds.), Serotonin and Behaviour pp. 469–475. Academic Press, New York
Goodwin, F. K., Wirz-Justice, A. and Wehr, T. A. (1982). Evidence that the pathophysiology of depression and the mechanism of action of antidepressant drugs both involve alterations in circadian rhythms. Adv. Biochem., Psychopharmacol., 31, 1
Grant, J. A. and Scrutton, M. C. (1980). Interaction of selective α-adrenoceptor agonists and antagonists with human and rat blood platelets. Br. J. Pharmacol., 71, 121
Green, A. R. and Nutt, D. J. (1983). Antidepressants. In Grahame-Smith, D. G. and Cowen, P. J. (Eds.), Psychopharmacology I. Part I: Pre-clinical Psychopharmacology, pp. 1–37. Excerpta Medica, Amsterdam
Halls, H. and Ögren, S. O. (1981). Effects of antidepressant drugs on different receptors in the brain. Europ. J. Pharmacol., 70, 393
Harlow, H. F. (1958). The nature of love. Am. Psychol., 13, 673
Healy, D., Carney, P. A. and Leonard, B. E. (1983). Monoamine related markers of depression. J. Psychiat. Res., 17, 251
Healy, D., Carney, P. A. and Leonard, B. E. (1985a). Circadian abnormalities in 5-HT uptake depression. In Redfern, P. A., Campbell, I. C., Davies, J. A. and Martin, K. F. (Eds.), Circadian Rhythms in the Central Nervous System, p. 249. Macmillan Press, London
Healy, D., Carney, P. A., O’Halloran, A. and Leonard, B. E. (1985b). Peripheral adreno-ceptors and serotonin receptors in depression. J. Affect. Dis., 17, 285.
Hirata, F. and Axelrod, J. (1978). Enzymatic synthesis and rapid translocation of phos-phatidylcholine by two methyltransferases in erythrocyte membranes. Proc. Natl. Acad. Sci. U.S.A., 15, 1718
Hollister, L. E., Davis, K. L., Overall, J. E. and Andesson, J. (1978). Excretion of MHPG in normal subjects. Arch. Gen. Psychiat., 35, 1410
Honecker, H., Fähndrich, E., Coper, H. and Helmchen, H. (1981). Serum DBH and platelet MAO in patients with depressive disorders. Pharmakopsychiatrie, 14, 10
Iversen, L. L. and MacKay, A. V. P. (1979). Pharmacodynamics of antidepressants and antimanic drugs. In Paykel, E. S. and Coppen, A. (Eds.), Psychopharmacology of Affective Disorders, pp. 60–72. Oxford University Press, Oxford
Jancsár, S. and Leonard, B. E. (1980). Effect of some antidepressant and other psychotropic drugs on the behaviour of olfactory bulbectomized rats in the ‘open field’ apparatus. Irish J. Med. Sci., 149, 80
Jancsár, S. and Leonard, B. E. (1981). The effects of olfactory bulbectomy on the behaviour of rats in the ‘open field’. Irish J. Med. Sci., 150, 3
Jancsár, S. and Leonard, B. E. (1983a). Behavioural and neurochemical interactions between chronic reserpine and chronic antidepressants: a possible model for the detection of atypical antidepressants. Biochem. Pharmacol., 32, 1569
Jancsár, S. and Leonard, B. E. (1983b). The olfactory bulbectomized rat as a model of depression. In Usdin, E., Goldstein, M., Friedhoff, A. J. and Georgotas, A. (Eds.), Frontiers in Neuropsychiatrie Research, pp. 357–372. Macmillan, New York
Jancsár, S. and Leonard, B. E. (1984). Changes in neurotransmitter metabolism following olfactory bulbectomy in the rat. Progr. Neuro-psychopharmacol Biol. Psychiat. (In press)
Kant, G. T., Bates, V. E., Lennox, R. H. and Meyerhoff, J. L. (1983). Effects of acute and chronic desmethylimipramine on levels of cyclic AMP in vivo. Biochem. Pharmacol., 32, 732
Kaufman, C. I. (1974). Mother/infant relations in monkeys and humans. In White, N. F. (Ed.), Ethology and Psychiatry, pp. 47–68. University of Toronto Press, Toronto
Kellar, K.H., Cascio, C. S., Butler, J. A. and Jurtzke, R.N. (1981). Differential effects of electroconvulsive shock and antidepressant drugs on serotonin α-2 receptors in rat brain. Europ. J. Pharmacol., 69, 515
Koide, T. and Matsushita, H. (1981). An enhanced sensitivity of muscarinic cholinergic receptor associated with dopaminergic receptor subsensitivity after chronic antidepressant treatment Life Sci., 28, 1139
Lampugnani, M. G. and De Gaetano, G. (1982). Comparative effects of ketanserin, a novel serotonergic receptor antagonist on 5-HT induced shape change and 5-HT uptake in rat and human platelets. Biochem. Pharmacol., 31, 3000
Langer, S. Z. (1977). Pre-synaptic receptors and their role in the regulation of transmitter release. Br. J. Pharmacol., 60, 481
Langer, G., Henize, G., Reim, B. and Matussek, N. (1975). Growth hormone response to d-amphetamine in normal controls and in depressed patients. Neurosci. Lett., 1, 185
Langer, S. Z., Zarifian, E., Briley, M., Raisman, R. and Sechter, D. (1981). High-affinity binding of 3H-imipramine in brain and platelets and its relevance to the biochemistry of affective disorders. Life Sci., 29, 211
Lecrubier, Y., Peuch, A. J., Jouvent, R., Simon, P. and Widlocher, D. (1980). A beta adren-ergic stimulant (salbutamol) versus clomipramine in depression. A controlled study. Br. J. Psychiat., 136, 354
Leonard, B. E. (1974). Some effects of a new tetracyclic antidepressant compound, Org. GB94, on the metabolism of monoamines in the rat brain. Psychopharmacology, 36, 221
Leonard, B. E. (1982). Current status of the biogenic amine theory of depression. Neuro-chem. Int., 4, 339
Leonard, B.E. (1984). Inter-relationship between neurotransmitters. Neuropharmacology, 23, 213
Leonard, B. E. (1986). Neurotransmitter receptors, endocrine responses and the biological substrates of depression: a review. Human Psychopharmacol., 1 (In press)
Maas, J. W., Pekirmenjian, H. and Jones, F. (1973). The identification of depressed patients olfactory bulbectomy in the rat. Int. Rev. Neurobiol., 22, 251
Lloyd, K. G., Morselli, P. L., Depoortere, H. Fountier, V., Zivkovic, B., Scatton, B., Broekkamp, C., Worms, P. and Bartholini, G. (1983). The potential use of GABA agonists in psychiatric disorders: evidence from studies with progabide in animal models and clinical trials. Pharmacol. Biochem. Behav., 18, 957
Maas, J. W., Pekirmenjian, H. and Jones, F. (1973). The identification of depressed patients who have a disorder of noradrenaline metabolism and/or disposition. In Usdin E. and Snyder, S. H. (Eds.), Frontiers in Catecholamine Research, pp. 1091–1096. Pergamon Press, New York
Maj, J., Palider, W. and Rawlow, A. (1979). Trazodone, a central serotonin antagonist and agonist. J. Neurol. Trans., 44, 237
McKinney, W. J., Young, L. D., Sumoi, S. T. and Davis, J. M. (1973). Chlorpromazine treatment in disturbed monkeys. Arch. Gen. Psychiat., 29, 490
McMillen, B. A., Warnock, W., German, D. C. and Shore, P. A. (1980). Effects of chronic desipramine treatment on rat brain noradrenergic responses to α-adrenergic drugs. Europ. J. Pharmacol., 61, 239
Matthews, A. (1981). Plasma measurement of β-endorphin-like immunoreactivity in depressives and other psychiatric subjects. Life Sci., 31, 1867
Matussek, N., Romisch, P. and Ackenheil, M. (1977). MHPG excretion during sleep deprivation in endogenous depression. Neuropsychobiology, 3, 23
Maubach, M., Diebold, K., Friedl, W. and Propping, P. (1981). Platelet MAO activity in patients with affective psychosis and their first degree relatives. Pharmakopsychiatrie, 14, 87
Meltzer, H. Y. and Fang, U. S. (1983). Central determination and dexamethasone suppression test. Arch. Gen. Psychiat., 40, 501
Meyerson, L. R., Wennogle, L. P., Abel, M. S., Coupet, J., Lippa, A. S., Rawh, C. E. and Beer, B. (1982). Human brain receptor alterations in suicide victims. Pharmacol Biochem. Behav., 17, 159
Minocherhomjee, A. M. and Roufogalis, B. D. (1982). Mechanisms of coupling of β-adrener-gic receptors to adenylate cyclase: an overview. Gen. Pharmacol., 13, 87
Montgomery, S. A. (1982). The non-selective effects of selective antidepressants. Adv. Biochem. Psychopharmacol., 32, 49
Murphy, D. L. and Weiss, R. (1972). Reduced platelet monoamine oxidase activity in blood platelets from bipolar depressed patients. Am. J. Psychiat., 128, 1351
Niskanen, P., Tamminen, T. and Viukari, M. (1975). Sulpiride vs. amitriptyline in the treatment of depression. Curr. Therap. Res., 17, 281
O’Connor, W. T., Jancsár, S. M. and Leonard, B. E. (1984). Comparison of the effects of nomifensin and its metabolite, 4-hydroxynomifensin on the behaviour of the bulbec-tomized rat. Proc. Roy. Soc. Med. Int. Congr. Symp. Ser. (In press)
Olpe, H. R. (1982). Molecular view of the treatment of depression. In Korf, J. and Pepplinkhnizen, L. (Eds.), Depression: Molecular and Psychologically Based Therapies — An Integrative View, pp. 21–46. TGO Foundation, Drachten
O’Neill, K. A. and Valentino, D. (1982). Escapability and generalization: effect on behavioural despair. Europ. J. Pharmacol., 78, 379
Oreland, L., Wiberg, A., Asberg, M., Traskman, L., Sjostrand, L., Thoren, P., Bertilsson, L. and Tybring, G. (1981). Platelet MAO activity and monoamine metabolites in cerebro-spinal fluid in depressed and suicidal patients and in healthy controls. Psychiat. Res., 4, 21
Pandey, G. N., Pysken, M. W., Garter, D. L. and Davis, J. M. (1979). Beta-adrenergic receptor function in affective illness. Am. J. Psychiat., 136, 675
Parkes, J. D., Thompson, C. and Quinn, N. (1982). Rolipram in Parkinson’s disease. In Proc. VIIth Int. Symp. on Parkinson’s Disease, Frankfurt, p. 53
Pazos, A., Cortés, R. and Palacios, J. M. (1985). Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II: Serotonin-2 receptors. Brain Res., 346, 231
Pazos, A. and Palacios, J. M. (1985). Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I: Serotonin-1 receptors. Brain Res., 346, 205
Peet, M. and Behagel, H. (1977). Mianserin: a decade of scientific development. Br. J. Clin. Pharmacol., 5, 59
Piagache, R. m. (1982). A peptide for the aged? Basic and clinical studies. In Wheatley, D. (Ed.)., Psychopharmacology of Old Age, pp. 67–96. Oxford University Press, Oxford
Pilc, A. and Lloyd, K. G. (1984). Effect of chronic antidepressant treatment on GABA-B receptors. Life Sci., 35, 2149
Pinder, R. M. (1985). Antidepressant drugs of the future. In Iversen, S. D. (Ed.), Psycho-pharmacology: Recent Advances and Future Prospects, p. 44. OUP, Oxford
Porsolt, R. D., Anton, G., Blavet, N. and Jalfre, M. (1978). Behavioural despair in rats: a new model sensitive to antidepressant treatments. Europ. J. Pharmacol., 47, 379
Prescott, L. F. and Proudfoot, A. T. (1981). Dangers of self-poisoning with antidepressants. Proc. Roy. Soc. Med. Int. Congr. Symp. Series, No. 46, 69
Przegalinski, E., Bigajska, K. and Lewandowska, A. (1981). The influence of rolipram on the central serotonergic system. Pharmakopsychiatrie, 14, 162
Raisman, R., Briley, M. and Langer, S. Z. (1979a). High affinity 3H-imipramine binding in rat cerebral cortex. Europ. J. Pharmacol., 54, 307
Raisman, R., Briley, M. S. and Langer, S. Z. (1979b). Specific tricyclic antidepressant binding sites in rat brain. Nature, Lond., 281, 148
Randrup, A. and Braestrup, C. (1977). Uptake inhibition of biogenic amines by newer antidepressant drugs: relevance to the dopamine hypothesis of depression. Psychopharmacology, 53, 309
Rehavi, M., Ranot, O., Yavetz, B. and Sokolovsky, M. (1980). Amitriptyline: long term treatment elevates alpha-adrenergic and muscarinergic receptor binding in mouse brain. Brain Res., 194, 443
Rehavi, M., Skolnick, P., Hulihan, B. and Paul, S. M. (1981). High affinity binding of 3H-desipramine to rat cerebral cortex: relationship to tricyclic antidepressant induced inhibition of norepinephrine uptake. Europ. J. Pharmacol., 70, 597
Rigter, H. and Van Riezen, H. (1978). Hormones and memory. In Lipton, M. A., DiMascio, A. and Kittam, K. F. (Eds.), Psychopharmacology: A Generation of Progress, pp. 677–689. Raven Press, New York
Rosloff, B. N. and Davis, J. M. (1974). Effect of iprindole on norepinephrine turnover and transport. Psychopharmacology, 40, 53
Ross, S. B., Hall, H., Renyi, A. L. and Westerlind, D. (1981). Effects of zimelidine on serotonergic and noradrenergic neurons after repeated administration in the rat. Psychopharmacology, 72, 219
Roth, M. and Kerr, T. A. (1970). Diagnosis of reactive depressive illness. In Price, H. (Ed.), Modern Trends in Psychological Medicine, Vol. 2, pp. 165–199. Butterworths, London
Rudzik, A. D., Hester, J. B., Tang, H. H., Straw, R. N. and Friis, W. (1973). Triazolobenzo-diazepines, a new class of central nervous system depressant compounds. In Garathini, S., Mussini, E. and Randall, O. (Eds.), The Benzodiazepines, pp. 285–297. Raven Press, New York
Schechter, M. D. and Chance, W. T. (1979). Non-specificity of behavioural despair as an animal model of depression. Europ. J. Pharmacol., 60, 139
Schwabe, U., Migake, M., Ohga, Y. and Daly, T. W. (1976). 4-(3-Cyclopentyloxy-4-meth-oxyphenyl)-2-pyrrokiolone (2K 62711): a potent inhibitor of adenosine cyclase 3′5′-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain. Molec. Pharmacol., 12, 900
Seligman, M. E. P. (1975). Helplessness. Freeman, San Francisco
Serra, G., Argiolas, A., Fadda, F. and Gessa, G. L. (1980). Hyposensitivity of dopamine ‘auto receptors’ induced by chronic administration of tricyclic antidepressants. Pharmacol Res. Commun., 12, 619
Sheard, M. (1969). The effect of p-chlorophenylalanine on behaviour in rats: relation to brain serotonin and 5-hydroxyindole acetic acid. Brain Res., 15, 524
Shimizu, T. and Fujita, M. (1981). Effect of β-adrenergic receptor blocking agent in depression as measured by plasma noradrenaline concentration and blood pressure. In Langer, S. Z. (Ed.), New Vistas in Depression, pp. 247–253. Pergamon Press, New York
Sjöstrom, R. (1973). Steady state levels of probenecid and their relation to acid mono-amine metabolites in human cerebrospinal fluid. Psychopharmacology, 25, 96
Snyder, S. H. (1980). Brain peptides as neurotransmitters. Science, N. Y., 209, 976
Soroko, F. E., Mehta, N. B., Maxwell, R. A., Ferris, R. M. and Schroeder, D. H. (1977). Buproprion hydrochloride (+/−)-α-tert-butylamino-3-chloropropiophenone HC1): a novel antidepressant agent. J. Pharm. Pharmacol., 29, 767
Sugrue, M. F. (1981). Current concepts on the mechanisms of action of antidepressant drugs. Pharmacol Therap., 13, 219
Sulser, F. (1978). Functional aspects of the norepinephrine coupled adenylate cyclase system in the limbic forebrain and its modification by drugs which precipitate or alleviate depression: molecular approaches to an understanding of affective disorders. Pharmaco-psychiatry, 11, 43
Sulser, F., Janowsky, A. J., Okada, F., Manier, D. A., and Mobley, P. L. (1983). Regulation of recognition and function of the norepinephrine receptor coupled adenylate cyclase system in brain: implications for the therapy of depression. Neuropharmacology, 22, 425
Trans, V. T., Kebovitz, R., Toll, L. and Snyder, S. H. (1981). 3H-doxepin interactions with histamine H1-receptors and other sites in guinea pig and rat brain homogenates. Europ. J. Pharmacol., 70, 501
Tricklebank, M. D., Forler, C., Middlemiss, D. N. and Fozard, J. R. (1985). Subtypes of the 5-HT receptor mediating the behavioural responses to 5-methoxy-N, N-dimethyl-tryptamine in the rat. Europ. J. Pharmacol, 117, 15
Tuomisto, J., Tukiainen, E. and Ahlfors, U. G. (1979). Decreased uptake of 5-hydroxytrypt-amine in blood platelets from patients with endogenous depression. Psychopharmacology, 65, 141
U’Prichard, D. C., Bechtel, W., Rouot, B. and Snyder, S. H. (1979). Multiple apparent alpha noradrenergic receptor binding sites in rat brain: effect of 6-hydroxydopamine. Molec. Pharmacol., 16, 47
Van Praag, H. M., Korf, J. and Schut, J. (1973). Cerebral monoamines and depression: an investigation with the probenecid technique. Arch. Gen. Psychiat., 28, 827
Van Riezen, H. (1972). Different central effects of the 5-HT antagonists mianserin and cyproheptadine. Arch. Int. Pharmacodyn., 198, 256
Van Riezen, H., Schnieden, H. and Wren, A. F. (1977). Olfactory bulb ablation in the rat: behavioural changes and their reversal by antidepressant drugs. Br. J. Pharmacol., 60, 521
Veith, R. C., Bielski, R. J., Bloom, V., Fawcett, J. A., Narasimhachari, N. and Friedel, R. O. (1983). Urinary MHPG excretion and treatment with desipramine or amitriptyline: prediction of response, effect of treatment and methodological hazards. J. Clin. Psycho-pharmacol., 3, 18
Vergnes, M. and Kark, P. (1963). De’clenchement du comportement d’agression inter-specifique. Rat-Souris par ablation bilatérale des bulbes olfactifs. C.R. Soc. Biol., 157, 1061
Vergnes, M. and Kempf, E. (1982). Effect of hypothalamic injections of 5,7-dihydroxy-tryptamine on elicitation of mouse killing in rats. Behav. Brain Res., 5, 387
Vetulani, J. Stawarz, R. J., Dingell, J. V. and Sulser, F. (1976). A possible common mechanism of action of antidepressant treatments. Arch. Pharm., 293, 109
Wachtel, H. (1982). Characteristic behavioural alterations in rats induced by rolipram and other selective adenosine cyclic 3′,5′-monophosphate phosphodiesterase inhibitors. Psychopharmacology, 77, 309
Wagner, H. R., Crutcher, K. A. and Davis, J. N. (1979). Chronic estrogen treatment decreases β-adrenergic responses in rat cerebral cortex. Brain Res., 171, 147
Waldmeier, P. (1982). Effects of antidepressant drugs on dopamine uptake and metabolism. J. Pharm. Pharmacol., 34, 391
Wallach, M. B. and Hedley, L. R. (1979). The effects of several antihistamines in a modified behavioural despair test. Fed. Proc., 38, 861
Wang, R. Y. and Aghajanian, G. K. (1980). Enhanced sensitivity of amygdaloid neurosis to serotonin and norepinephrine after chronic antidepressant treatment. Commun. Psycho-pharmacol., 4, 83
Whitaker, P. M. and Cross, A. J. (1980). 3H-mianserin binding in calf caudate: possible involvement of serotonin receptors in antidepressant drug action. Biochem. Pharmacol., 29, 2709
Whitlock, F. A. (1977). Depression and suicide. In Burrows, G. D. (Ed.), Handbook of Studies on Depression, pp. 379–403. Excerpta Medica, Amsterdam
Wirz-Justice, A. and Campbell, I. (1982). Antidepressant drugs can slow or dissociate circadian rhythms. Experientia, 38, 1301
Wood, K. and Coppen, A. (1981). Platelet alpha-adrenoceptor sensitivity in depressive illness. Adv. Biol. Psychiat., 7, 85
Young, J. P. R., Hughes, W. C. and Lader, M. H. (1976). A controlled comparison of flu-penthixol and amitriptyline in depressed out patients. Br. Med. J., i, 1116
Zerbin-Rüdin, E. (1980). Genetics of affective psychosis. In Van Praag, H., Lader, M. A., Rafaelsen, O. J. and Sachar, E. J. (Eds.), Handbook of Biological Psychiatry. Part III, pp. 35–58. Marcel Dekker, New York
Ziegler, M. G., Wood, J. J., Lake, C. R. and Kopin, I. J. (1977). Norepinephrine and MHPG gradients in human CSF. Am. J. Psychiat., 134, 565
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Copyright information
© 1986 The Editor and the Contributors
About this chapter
Cite this chapter
Leonard, B.E. (1986). Antidepressant Drugs. In: Woodruff, G.N. (eds) Mechanisms of Drug Action. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-08026-7_6
Download citation
DOI: https://doi.org/10.1007/978-1-349-08026-7_6
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-08028-1
Online ISBN: 978-1-349-08026-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)